FurchgottRF, ZawadzkiJV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature1980;288(5789):373–376.
2.
IgnarroLJ, BugaGM, WoodKS, ByrnsRE, ChaudhuriG.Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA1987;84(24):9265–9269.
3.
PalmerRM, FerrigeAG, MoncadaS.Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature1987;327(6122):524–526.
4.
PalmerRM, ReesDD, AshtonDS, MoncadaS.L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun1988;153(3):1251–1256.
5.
IgnarroLJ. Endothelium-derived nitric oxide: actions and properties. FASEB J1989;3(1):31–36.
GibsonQH, RoughtonFJW. The kinetics of equilibria of the reac-tions of nitric oxide with sheep hemoglobin. J Physiol1957;136:507–526.
8.
OdaH, NogamiH, KusumotoS, NakajimaT, KurataA, ImaiK.Long-term exposure to nitric oxide in mice. J Jpn Soc Air Pollut1976;11:150–160.
9.
HugodC.Effect of exposure to 43 ppm nitric oxide and 3.6 ppm nitrogen dioxide on rabbit lung. Int Arch Occup Environ Health1979;42(3-4):159–167.
10.
HigenbottamT, Pepke-ZabaJ, ScottJ, WoolmanP, CouttsC, WallworkJ.Inhaled "endothelium-derived relaxing factor" (EDRF) in primary hypertension (abstract). Am Rev Respir Dis1988;137(4 Part 2):107.
11.
Pepke-ZabaJ, HigenbottamTW, Dinh-XuanAT, StoneD, WallworkJ.Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet1991;338(8776):1173–1174.
12.
FrostellC, FratacciMD, WainJC, JonesR, ZapolWM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation1991;83(6):2038–2047. Published erratum appears in Circulation 1991;84(5):2212.
RobertsJD, PolanerDM, LangP, ZapolWM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):818–819.
15.
KinsellaJP, NeishSR, ShafferE, AbmanSH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet1992;340(8823):819–820.
16.
FalkeKJ, RossaintR, PisonU, et al. Inhaled nitric oxide selectively reduces pulmonary hypertension in severe ARDS and improves gas exchange as well as right heart ejection fraction: a case report (abstract). Am Rev Respir Dis1991;143(4 Part 2):A248.
17.
RossaintR, FalkeKJ, LopezF, SlamaK, PisonU, ZapolWM. Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med1993;328(6):399–405.
18.
GerlachH, PappertD, LewandowskiK, RossaintR, FalkeKJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory dis-tress syndrome. Intensive Care Med1993;19(8):443–449.
19.
AssreuyJ, CunhaFQ, LiewFY, MoncadaS.Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol1993;108(3):833–837.
20.
KiffRJ, MossDW, MoncadaS.Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implications for inhalation therapy. Br J Pharmacol1994;113(2):496–498.
21.
VillarJ, BlazquezMA, LubilloS, QuintanaJ, ManzanoJL. Pulmonary hypertension in acute respiratory failure. Crit Care Med1989;17(6):523–526.
22.
Dinh-XuanAT, HigenbottamTW, ClellandCA, Pepke-ZabaJ, CremonaG, ButtAY, et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med1991;324(22):1539–1547.
23.
HögmanM, FrostellC, ArnbergH, HedenstiernaG.Bleeding time prolongation and NO inhalation (letter). Lancet1993;341(8861):1664–1665.
24.
HögmanM, FrostellC, ArnbergH, SandhagenB, HedenstiernaG.Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand1994;151(1):125–129.
25.
SamamaCM, DiabyM, FellahiJL, MdhafarA, EyraudD, ArockM, et al. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology1995;83(1):56–65.
RadomskiMW, VallanceP, WhitleyG, FoxwellN, MoncadaS.Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res1993;27(7):1380–1382.
RadomskiMW, PalmerRM, MoncadaS.The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol1987;92(3):639–646.
30.
RadomskiMW, PalmerRM, MoncadaS.An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA1990;87(13):5193–5197.
31.
RadomskiMW, PalmerRM, MoncadaS.Characterization of the L-arginine/nitric oxide pathway in human platelets. Br J Pharmacol1990;101(2):325–328.
32.
MauriceDH, HaslamRJ. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of ade-nylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol Pharmacol1990;37(5):671–681.
33.
NguyenBL, SaitohM, WareAJ. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol1991;261(4 Pt 2):H1043–H1052.
34.
MichelsonAD, BenoitSE, FurmanMI, BreckwoldtWL, RohrerMJ, BarnardMR, LoscalzoJ.Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol1996;270(5 Pt 2):H1640–H1648.
35.
GerzerR, KarrenbrockB, SiessW, HeimJM. Direct comparison of the effects of nitroprusside, SIN-1, and various nitrates on platelet aggregation and soluble guanylate cyclase activity. Thromb Res1988;52(1):11–21.
36.
KehD, GerlachM, KürerI, SeilerS, KernerT, FalkeKJ, GerlachH.The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with alpha-thrombin. Blood Coag Fibrinolysis1996;7(6):615–624.
37.
RossaintR, GerlachH, Schmidt-RuhnkeH, PappertD, LewandowskiK, SteudelW, FalkeK.Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest1995;107(4):1107–1115.
38.
DellingerRP, ZimmermanJL, TaylorRW, StraubeRC, HauserDL, CrinerGJ, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med1998;26(1):15–23.
39.
MichealJR, BartonRG, SaffleJR, MoneM, MarkewitzBA, HillierK, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med1998;157(5 Pt 1):1372–1380.
40.
TroncyE, ColletJP, ShapiroS, GuimondJG, BlairL, DucruetT, et al. Inhaled nitric oxide in acute respiratory distress syndrome: a pilot randomized controlled study. Am J Respir Crit Care Med1998;157(5 Pt 1):1483–1488.
41.
LundinS, MangH, SmithiesM, StenquistO, FrostellC, for the European Study Group of Inhaled Nitric Oxide. Inhalation of nitric oxide in acute lung injury: Preliminary results of a European multi-center study (abstract). Intensive Care Med1997;23(Suppl 1):S2.
42.
GerlachH, RossaintR, PappertD, FalkeKJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest1993;23(8):499–502.
43.
GustafssonLE, LeoneAM, PerssonMG, WiklundNP, MoncadaS.Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun1991;181(2):852–857.
44.
GerlachH, RossaintR, PappertD, KnorrM, FalkeKJ. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet1994;343(8896):518–519.
45.
JiaL, BonaventuraJ, StamlerJS. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature1996;380(6571):221–226.
46.
StamlerJS, JiaL, EuJP, McMahonTJ, DemchenkoIT, BonaventuraJ, GernertK, PiantadosiCA. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science1997;276(5321):2034–2037.